Massive Intoxication with 70 Tablets of Apixaban: A Case Report

Abstract Apixaban is a direct oral anticoagulation agent that exerts its effect through the direct inhibition of factor Xa. We treated a case of massive intoxication with 70 tablets of apixaban and have presented the clinical course of the associated anti-Xa activities. A 49-year-old woman was admit...

Full description

Saved in:
Bibliographic Details
Published inCase reports in acute medicine Vol. 6; no. 1; pp. 13 - 18
Main Authors Kobayashi, Tadahiro, Saito, Satoko, Takada, Masayuki, Sakaguchi, Kento, Takahashi, Kazunori, Tanaka, Ken, Kawamae, Kaneyuki, Nakane, Masaki
Format Journal Article
LanguageEnglish
Published Basel, Switzerland Karger Publishers 12.09.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Apixaban is a direct oral anticoagulation agent that exerts its effect through the direct inhibition of factor Xa. We treated a case of massive intoxication with 70 tablets of apixaban and have presented the clinical course of the associated anti-Xa activities. A 49-year-old woman was admitted to the emergency department approximately 1.5 h after impulsive self-intoxication with 175 mg of apixaban. She developed coagulopathy with prothrombin time-international normalized ratio (PT-INR) of 3.65, activated partial thromboplastin time of 56.5 s, and antithrombin activity (AT) of >150% (at 1.5 h post-ingestion). The patient’s initial and peak anti-Xa activity was 17.7 IU/mL, and its elimination displayed first-order kinetics with a half-life of 10.5 h. The patient’s anti-Xa activity was within the therapeutic dose range at 26 h post-ingestion, and she recovered without experiencing any bleeding complications. Her coagulopathy also returned to normal level at the same timing. This result suggests that PT-INR and AT can be used as substitute markers of overwhelmed anticoagulation following massive overdose of apixaban. A case of apixaban overdose with associated anti-Xa activities was presented. There was favorable resolution of anticoagulation without specific treatments.
ISSN:2504-5288
2504-5288
DOI:10.1159/000533520